Bio-Techne Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| TE1.F | 301080.SZ | 002630.KS | 3759.HK | 1548.HK | MRVI | |
|---|---|---|---|---|---|---|
| Market cap | 9.86B | 15.23B | 40.88B | 47.88B | 74.98B | 2.66B |
| P/E (TTM) | 63.5 | 84.1 | — | 24.6 | — | — |
| Forward P/E | 7.0 | — | — | 15.0 | 83.8 | -71.4 |
| Price/book | 5.2 | 5.7 | — | 2.5 | 2.4 | 5.2 |
| Dividend yield | 0.43% | 0.63% | — | 0.84% | — | — |
| 1-year change | +13.91% | +57.55% | −37.97% | +14.61% | +113.57% | +117.53% |
| Today | −2.30% | −4.52% | −4.17% | −5.10% | −4.20% | −5.02% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All TE1.F news ›Bio-Techne opens GMP small-molecule manufacturing facility in Bristol
pharmafile | October 13, 2026 | News story | | Cardiology, Cleanroom, Diabetes, Haematology, Neurology, Rare Diseases, cell therapies, manufacturing and production, small molecules Bio-Techne has opened a new facility in Bristol…
Bio-Techne opens new GMP facility in Bristol to boost cell therapy manufacturing capacity.
Bio-Techne Corporation has launched a new GMP-grade small molecule manufacturing facility in Bristol, UK, enhancing its global infrastructure for cell therapy production. This 10,000-square-foot site features advanced cleanrooms designed…
Bio-Techne expands global GMP manufacturing network with new Bristol facility to advance scalable cell therapy development
Bio-Techne Corporation, a global provider of life science tools, reagents and diagnostic products, today announced the opening of a new manufacturing facility for Good Manufacturing Practice (GMP) grade small molecules in Bristol, United…
NASDAQ listed Bio-Techne hails South West's fast-growing life sciences sector as it opens Bristol cell therapy facility
Site manufactures molecules to treat conditions including type 1 diabetes and Parkinson's NASDAQ listed Bio-Techne hails South West’s fast-growing life sciences sector as it opens Bristol cell therapy facility More from South West -…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com2
-
bioprocessintl.com1
-
businessnewsthisweek.com1
-
contractpharma.com1
-
moomoo.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 14 articles, not a forecast.